You are here: Industry Insights > Shingles

News List

GSK Singapore announces availability of Shingrix in Singapore for shingles prevention prnasia
January 10, 2022
GlaxoSmithKline (GSK) Singapore announced that a new vaccine to help protect against shingles, Shingrix, is now available in Singapore.
Pfizer and BioNTech sign new global collaboration agreement to develop first mRNA-based shingles vaccine WorldPharmaNews
January 07, 2022
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a new research, development and commercialization collaboration to develop a potential first mRNA-based vaccine for the prevention of shingles...
US FDA approves Shingrix to prevent shingles in immuno-compromised adults expresspharma
July 28, 2021
Shingrix, a non-live, recombinant sub-unit adjuvanted vaccine, given intramuscularly in two doses, was initially approved by FDA in 2017 for the prevention of shingles in adults 50 years of age or older.
Shingrix Approved for Shingles Prevention in Immunocompromised Adults americanpharmaceuticalreview
July 27, 2021
GlaxoSmithKline plc announced that the US FDA has approved Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the prevention of shingles (herpes zoster) in adults aged 18 years and older who are or who will be at increased risk of shingles due to ...
Chickenpox Vaccine Shields Kids From Shingles, Too drugs
June 11, 2019
Chickenpox Vaccine Shields Kids From Shingles, Too.
NanoViricides Reaches Agreement on Terms of License for Shingles Virus Drug Development americanpharmaceuticalreview
February 27, 2019
NanoViricides has reached an agreement on the terms of the license for the drug development against VZV, the virus that causes chickenpox in children and shingles in adults....
GSK's shingles vaccine scores US approval pharmafile
October 24, 2017
GlaxoSmithKline has announced that its shingles vaccine Shingrix (Zoster Vaccine Recombinant, Adjuvanted) has been awarded FDA approval for the prevention of the disease in patients aged 50 or older.
GSK's Shingles vaccine gets unanimous recommendation from FDA Panel biospectrumasia
September 15, 2017
A U.S. Food and Drug Administration advisory panel on Wednesday voted 11-0 for the vaccine for its safety and efficacy